Alexion Says U.S. Health Inspector General Is Part of DOJ Probe
- Stock declines 3.2 percent to $121.09 in New York trading
- HHS OIG investigates waste and fraud in U.S. health programs
This article is for subscribers only.
Alexion Pharmaceuticals Inc. is under investigation by the U.S. Department of Health and Human Services’ Office of Inspector General, related to a probe of the drugmaker’s support for charities that aid Medicare patients by the U.S. Attorney’s Office in Massachusetts.
“We are aware that the U.S. Department of Health and Human Services Office of Inspector General is working on this inquiry with the U.S. Attorneys’ Office and the Department of Justice,” Alexion said Thursday in a statement.